NMN vs Rhodiola for energy / fatigue: which has better evidence?
A tie on evidence grade for energy / fatigue (NMN Grade — vs Rhodiola Grade C). For energy / fatigue, Rhodiola has the stronger evidence grade.
Head to head
| NMN | Rhodiola | |
|---|---|---|
| Grade | not well studied | grade C |
| Certainty | very-low | low |
| Effect | not adequately studied for fatigue/energy outcomes in humans | small reductions in fatigue in stressed adults; studies are short and small |
| Studied dose | — | — |
| Population | — | — |
| Safety | 0 modeled interaction(s) | 1 modeled interaction(s) |
Grade or certainty not assigned — evidence bucket does not yet warrant a graded claim.
Direct comparison evidence
There are no direct RCTs in our corpus comparing NMN and Rhodiola head-to-head for energy / fatigue. What we present above is an indirect comparison: each side's own trials, contrasted. This is standard practice for supplement comparisons — dose, population, and outcome-instrument differences between the two evidence bases add uncertainty on top of each side's own grade.
Can you take both?
No modeled interaction between NMN and Rhodiola in our corpus. Absence of a recorded interaction is not proof of additive benefit — combined-effect trials are usually absent for supplement pairs, so treat "stack" claims skeptically.
Decision guidance
- If certainty matters most — choose whichever side carries the higher certainty rating at a similar grade.
- If you're on medications — check each side's interaction pages before deciding; safety differences dominate small evidence-grade gaps.
- If your population is under-studied — the smaller-effect side with better population evidence often wins over the higher-grade side studied in a different demographic.
- If cost matters — form and dose page differences (NMN vs Rhodiola) can invert the practical winner.
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
Which has stronger evidence: NMN or Rhodiola for energy / fatigue?
NMN carries Grade — at very-low certainty; Rhodiola carries Grade C at low. The stronger evidence points to a tie, subject to the caveat that direct head-to-head trials are usually absent for supplement pairings.
Can I take NMN and Rhodiola together?
No modeled interaction between NMN and Rhodiola; combining is not documented to be problematic, but combined-effect trials are also absent, so treat additive benefit claims skeptically.
Have NMN and Rhodiola been compared head-to-head?
Direct RCTs comparing the two for energy / fatigue are uncommon. This page contrasts each side's own trial evidence — that is an indirect comparison, which introduces confounds from population and dose differences. See the direct-comparison block above.
What decides between NMN and Rhodiola for me?
Read the decision guidance below — the split usually comes down to population fit, interaction risk with your other medications, and how much certainty you want behind the recommendation.
Related
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. NMN vs Rhodiola for energy / fatigue. https://evidencebased.info/compare/nmn-vs-rhodiola-for-energy. Updated 2026-07-14.
BibTeX
@misc{substrate_nvsrhodiolaforenergy,
author = {Substrate editorial},
title = {NMN vs Rhodiola for energy / fatigue},
year = {2026},
url = {https://evidencebased.info/compare/nmn-vs-rhodiola-for-energy},
note = {evidencebased.info}
}